Development of c-Kit-expressing small-cell lung cancer in a chronic myeloid leukemia patient during imatinib treatment [2]

Journal of the National Cancer Institute

Volumn 96, Issue 22, 2004, Pages 1723-1724

  Gambacorti Passerini, Carlo ^a,b   Piazza, Rocco ^a   Tornaghi, Lucia ^c   Pilotti, Silvana ^d   Pogliani, Enrico ^c  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b MCGILL UNIVERSITY   (Canada)

^c SAN GERARDO HOSPITAL   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CARBOPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; IMATINIB; STEM CELL FACTOR; VINCRISTINE;

ADULT; ASTHENIA; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CIGARETTE SMOKING; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG RESPONSE; DYSPNEA; GENE SEQUENCE; HUMAN; LETTER; LUNG SMALL CELL CANCER; MALE; MORTALITY; PLEURA EFFUSION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIDE EFFECT; SMOKING HABIT; THORAX RADIOGRAPHY; TUMOR BIOPSY;

ANTINEOPLASTIC AGENTS; BRONCHOSCOPY; CARCINOMA, SMALL CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, MYELOID, CHRONIC; LUNG NEOPLASMS; MALE; MIDDLE AGED; PIPERAZINES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES;

EID: 9744250107     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djh330     Document Type: Letter

References (7)

1. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, et al. Effects of a selective inhibitor of the Ab1 tyrosine kinase on the growth of Bcr-Ab1 positive cells. Nat Med 1996;2:561-6.
2. Kantarjian H, Sawyers C, Hochhaus A, Guilhot F, Schiffer C, Gambacorti-Passerini C, et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic mylogenous leukemia. New Engl J Med 2002;346:645-52.
3. Gambacorti-Passerini C, Gunby R, Piazza R, Galietta A, Rostagno R, Scapozza L. Molecular mechanisms of resistance to imatinib in Ph-positive leukemias. Lancet Oncol 2003;4: 75-85.
4. Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 2003;21:4342-9.
5. Krystal GW, Hines SJ, Organ CP. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor. Cancer Res 1996;56:370-6.
6. Ruchatz H, Puttini M, Cleris L, Formelli F, Pilotti S, Gambacorti-Passerini C. Effect of STI571 on haematopoietic recovery following idarubicin exposure. Leukemia 2003;17:298-304.
7. Johnson BE, Fischer T, Fischer B, Dunlop D, Rischin D, Silberman S, et al. Phase II study of imatinib in patients with small cell lung cancer. Clin Can Res 2003;9:5880-7.